MY CLINIC
The cost of stem cell treatment for multiple sclerosis (MS) in the Czech Republic typically ranges from $15,000. Prices vary depending on the treatment protocol (autologous vs. allogeneic stem cells), the clinic’s expertise, length of hospital stay, and whether advanced immunosuppression is required. In the United States, the average cost is $31,500 (per National MS Society). This means treatment in the Czech Republic can be about 52% less than in the U.S.
Packages in the Czech Republic usually include pre-treatment evaluation, stem cell harvesting (often bone marrow or adipose-derived), cell processing, infusion, hospital stay, and follow-up visits. In the U.S., listed prices may cover only the procedure, with separate charges for hospitalization, lab tests, and aftercare. Always confirm what’s included in each clinic’s offer.
Why choose the Czech Republic for stem cell treatment for multiple sclerosis (MS)?
Access advanced Stem cell treatment for multiple sclerosis (MS) solutions in trusted clinics from $15,000.
| Czech Republic | Turkey | Austria | |
| Stem cell treatment for multiple sclerosis (MS) | from $15,000 | from $9,000 | ≈ $18,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Stem cell treatment for multiple sclerosis (MS) upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem cell treatment for multiple sclerosis (MS) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem cell treatment for multiple sclerosis (MS) journey.
Stem cell transplantation is not a standard, approved cure for multiple sclerosis in Czech hospitals. Local healthcare uses disease-modifying therapies as frontline care. Specialized centers perform autologous hematopoietic stem cell transplantation only for aggressive, treatment-refractory cases under strict clinical protocols rather than as routine practice.
Bookimed Expert Insight: Czech clinics like MY CLINIC in Prague collaborate with top medical faculties to maintain safety. While costs range from $15,000, patients should prioritize clinics with SAK accreditation. This specific certification confirms rigorous quality standards for inpatient care during the intensive recovery phase.
Patient Consensus: Patients emphasize that timing is vital because treating advanced disability often yields fewer benefits. Many highlight the grueling nature of the chemotherapy reset but value the potential to halt active disease relapses.
Czech clinics explore autologous hematopoietic stem cell transplantation (aHSCT) and mesenchymal stem cell therapy (MSC) for multiple sclerosis. These methods target aggressive relapsing-remitting MS through immune system resets or anti-inflammatory support. Institutions like the Institute of Hematology and Blood Transfusion coordinate these cellular therapies.
Bookimed Expert Insight: While hematopoietic stem cell transplantation averages $15,000 in the Czech Republic, the real value lies in the academic ties. Centers like MY CLINIC work with Charles University, ensuring protocols align with current European research standards rather than just commercial interests.
Patient Consensus: Patients emphasize that hematopoietic stem cell transplantation acts as an immune reset rather than a cure for existing damage. Success usually means stopping new relapses, though the recovery period after chemotherapy is physically demanding.
Cellthera in Brno is a primary private provider for regenerative stem cell treatments in the Czech Republic. They use adult stem cells from fat tissue or bone marrow. Medical centers like MY CLINIC in Prague provide general care but focus on diagnostics and outpatient specialty services.
Bookimed Expert Insight: While boutique clinics in Prague like MY CLINIC or Canadian Medical serve international patients, they function as multi-specialty hubs. True stem cell applications for chronic conditions are often separate from these general medical centers. Patients save about 52% compared to US costs, but must verify if the clinic offers hospital-based transplants or simple injections.
Patient Consensus: Patients emphasize distinguishing between hospital-based transplants and private injections. Many suggest prioritizing Prague hospital centers over smaller clinics for complex autoimmune needs.
Specialized stem cell care for multiple sclerosis in the Czech Republic is centered in Prague and Brno. Treatment is anchored by JCI or SAK accredited university hospitals and private institutes. Key hubs include the General University Hospital in Prague and specialized regenerative centers like Cellthera Clinic in Brno.
Bookimed Expert Insight: Czech Republic centers prioritize autologous hematopoietic stem cell transplantation (HSCT). This hospital-based approach uses oncology-style conditioning rather than simple injections. Facilities like MY CLINIC maintain high safety standards through SAK (United Accreditation Commission) oversight. Patients often save up to 52% compared to US costs for these intensive medical protocols.
Patient Consensus: Patients emphasize choosing hospital-based programs with both neurology and hematology teams. They warn that HSCT is a serious medical procedure involving chemotherapy, not a wellness treatment.